SCHEMBL7961201

SCHEMBL7961201

O=S(O)c1ccc2cc(Br)ccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.46
MAPT P10636 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
NCEH1 Q6PIU2 1/20 0.43
LMNA P02545 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
ERN1 O75460 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
TLR2 O60603 1/20 0.36
TEK Q02763 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5632527 0.98 CYP2A6 (0.45) CYP2A6MAPTALDH1A1KDM4EMEN1
SCHEMBL29988400 0.78 ALDH1A1 (0.46) CYP2A6MAPTALDH1A1KDM4EMEN1
SCHEMBL16938449 0.78 ALDH1A1 (0.46) CYP2A6MAPTALDH1A1KDM4EMEN1
SCHEMBL664585 0.78 ALDH1A1 (0.46) CYP2A6MAPTALDH1A1KDM4EMEN1
SCHEMBL5632523 0.78 CYP2A6 (0.45) CYP2A6MAPTALDH1A1KDM4EMEN1
SCHEMBL6652905 0.77 CYP2A6 (0.44) CYP2A6ALDH1A1MEN1KMT2ALMNA
SCHEMBL11335899 0.77 ALDH1A1 (0.45) CYP2A6MAPTALDH1A1KDM4EMEN1
SCHEMBL1583773 0.77 ALDH1A1 (0.45) CYP2A6MAPTALDH1A1KDM4EMEN1
SCHEMBL3152266 0.77 ALDH1A1 (0.45) CYP2A6MAPTALDH1A1KDM4EMEN1
Ammonia Solution, Strong SCHEMBL3156815 0.77 ALDH1A1 (0.45) CYP2A6MAPTALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 US disclosed
EP-0880501-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1998-12-02 EP disclosed
WO-1997028128-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1997-08-07 WO disclosed